EuroPCR 2016: The best of interventional cardiovascular medicine

(22:7)

EuroPCR 2016 Highlights: Peripheral Interventions

(4:49)

HIGHLIGHTS - What not to miss at EuroPCR 2016

(5:46)

EuroPCR 2016: An Introduction to Simple Education

(4:42)

EuroPCR 2016: Tavi in 2016 - Reflections on Partner2A

(9:36)

EuroPCR 2016: Education \u0026 Innovation in Cardiovascular Interventions

(1:13)

Complex PCI in coronary calcified lesions, the right tools and techniques - EuroPCR 2021

(56:39)

Is PCI enough in STEMI? - EuroPCR 2022

(43:28)

Physiologic guidance and optimisation in multivessel disease - EuroPCR 2023

(45:19)

EuroPCR 2023 Awards

(52:46)

Defining together the ideal TAVI platform of the future - EuroPCR 2023

(1:5:50)

Pierre Rolland's Colnago V1-R

(3:28)

Hot Tips - Calculating the Aortic Valve Area Using the Continuity Equation

(5:3)

แดนซ์มันๆ NONSTOP DANCE 2016 - DJ PORPUI

(58:54)

Where deliverability matters: challenging cases requiring a low profile - EuroPCR 2021

(44:54)

Innovations in TMVR and Intrepid trial updates - EuroPCR 2023

(1:6)

EuroPCR 2016: Chronic Total Occlusions in 2016

(16:13)

A glimpse of EuroPCR 2016

(1:42)

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Darren Mylotte

(1:2)

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Thomas Walther

(58)

EuroPCR 2016 Highlights: Peripheral Interventions

(1:56)

EuroPCR 2016 Highlights: Best abstracts and best clinical case

(4:48)

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Lars Sondergaard

(54)

EuroPCR 2016 Highlights: Coronary Interventions

(4:40)

EuroPCR 2016: Master DAPT study announcement

(8:44)

EuroPCR 2016: Special Edition Tuesday 17 May

(4:4)

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Jean François Obadia

(1:19)